Acquire Immune Deficiency Syndrome Bovine Spongiform Encephalopathy Male Circumcision Acquire Immune Deficiency Syndrome Patient Isobutyl Nitrite 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Arno P.S., and Feiden K.L., 1992, Against the odds: the story of AIDS drug development, politics and profits. New York: HarperCollins.Google Scholar
  2. Attaran A, and Sachs T, 2001, Defining and refining international donor support for combating the AIDS pandemic. Lancet 357: 57–61.PubMedCrossRefGoogle Scholar
  3. Auvert R., et al., 2005, Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med 2: e298.PubMedCrossRefGoogle Scholar
  4. Barlett J.G., 2002, The Johns Hopkins Hospital 2002 Guide to medical care of patients with HIV infection. 10th edn., Baltimore: Lippincot Williams & Wilkins. Cited in Palmer, 2003.Google Scholar
  5., 2006, CDC's revised recommendations for HIV testing of adults, adolescents, and pregnant women in health care settings. September 22.
  6. Centers for Disease Control (CDC), 1981a, Pneumocystis pneumonia – Los Angeles. Morb Mort Wkly Rep 30: 250–252.Google Scholar
  7. Centers for Disease Control (CDC), 1981b, Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men – New York City and California. Morb Mort Wkly Rep 30: 305–308.Google Scholar
  8. Centers for Disease Control (CDC), 1982a, Pneumocystis carinii pneumonia among persons with haemophilia. Morb Mort Wkly Rep 31: 353–354, 360–361.Google Scholar
  9. Centers for Disease Control (CDC), 1982b, Acquired Immune Deficiency Syndrome (AIDS): precautions for clinical and laboratory staffs. Morb Mort Wkly Rep 31: 377–380.Google Scholar
  10. Centers for Disease Control (CDC), 1984, Summary – cases specified notifiable diseases, United States. Morb Mort Wkly Rep 33: 4–5.Google Scholar
  11. Connor E.M., et al., 1994, Reduction of maternal infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 331: 1173–1180.PubMedCrossRefGoogle Scholar
  12. Duesberg P., and Rasnick D., 1998, The AIDS dilemma: drug diseases blamed on a passenger virus. Genetica 104: 85–132.PubMedCrossRefGoogle Scholar
  13. Food and Drug Administration, 2006, FDA News. Washington DC: US Department of Health and Human Services. 12 July.
  14. Glynn M., and Rhodes P., 2005, Estimated HIV prevalence in the United States at the end of 2003. Presented at the National HIV Prevention Conference, Atlanta, 12–15 June.–B1101.
  15. Gottlieb M.S., 2001, AIDS – Past and future. N Engl J Med 344: 1788–1790.PubMedCrossRefGoogle Scholar
  16. Gottlieb M.S., et al., 1981, Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 305: 1425–1431.PubMedGoogle Scholar
  17. Kaiser Network, 2006, Global HIV/AIDS Timeline.
  18. Leonidas J.R., and Hyppolite N., 1983, Haiti and the acquired immunodeficiency syndrome. Ann Int Med 98: 1020–1021.PubMedGoogle Scholar
  19. Masquelier B., et al., 2005, Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms data from seroconverters in the CASCADE collaboration from 1987 to 2003. J AIDS 40: 505–511.Google Scholar
  20. Masur H., et al., 1981, An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med 305: 1431–1438.PubMedGoogle Scholar
  21. Merson M.H., 2006, The HIV-AIDS pandemic at 25–The global response. N Engl J Med 354: 2421–2417.CrossRefGoogle Scholar
  22. New Mexico AIDS Education and Training Center, 2006, Fact Sheet 158. AIDS myths and misunderstandings. University of New Mexico Health Sciences Center. Revised 18 April 2006.
  23. New Mexico AIDS Education and Training Center, 2006, Fact Sheet 206. How to spot HIV/AIDS fraud. University of New Mexico Health Sciences Center. Revised 10 August 2006.
  24. Nwokike J.L., 2005, Baseline data and predictors of adherence in patients on anti-retroviral therapy in Maun General Hospital, Botswana. Essential Drugs Monitor 34: 12–13.Google Scholar
  25. Pallela F.J. Jr., et al., 1998, Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 238: 853–860.CrossRefGoogle Scholar
  26. Palmer C., 2003, HIV treatments and highly active anti-retroviral therapy. Austr Prescr 26 (3): 59–61.Google Scholar
  27. Sepkowitz K.A., 2001, AIDS – The first 20 years. N Engl J Med 344: 1764–1772.PubMedCrossRefGoogle Scholar
  28. Sepkowitz K.A., 2006, One disease, two epidemics – AIDS at 25. N Engl J Med 354: 2411–2414.PubMedCrossRefGoogle Scholar
  29. Shafer R.W., et al., 1989, Successful prophylaxis of Pneumocystis carinii pneumonia with trimethoprim – sulfamethoxazole in AIDS patients with previous allergic reactions. J AIDS 2: 389–393.Google Scholar
  30. Shilts R., 1987, And the band played on – politics, people and the AIDS epidemic. New York: St. Martin's Press.Google Scholar
  31. Siegal F.P., et al., 1981, Severe acquired immunodeficiency in male homosexuals manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med 305: 1439–1444.PubMedGoogle Scholar
  32. Steinbrook R., and Drazen J.M., 2001, AIDS – Will the next 20 years be different (Editorial). N Engl J Med 344: 1781–1782.PubMedCrossRefGoogle Scholar
  33. Stewart G.T., et al., 2000, The Durban Declaration is not accepted by all. Nature 407: 286.PubMedCrossRefGoogle Scholar
  34. Stover J., et al., 2006, The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries. Science 311: 1474–1476.PubMedCrossRefGoogle Scholar
  35. Swarns R.L., 2001, Drug makers drop South Africa suit over AIDS medicine. New York Times. April 20: A1. Cited in: Steinbrook & Drazen, 2001.Google Scholar
  36. UNAIDS, 2006, 2006 Report on the global AIDS epidemic. Geneva: UNAIDS.
  37. UNAIDS/WHO, 2005, AIDS epidemic update. Geneva: UNAIDS-WHO, p 5.Google Scholar
  38. Website: Accessed on 20 September 2006.
  39. Website: Accessed on 20 September 2006.
  40. Whyte S.R., et al., 2005, Accessing retroviral drugs: dilemmas for families and health workers. Essent Drugs Monit 34: 14–15.Google Scholar

Copyright information

© Springer 2007

Personalised recommendations